The role of KiSS1 gene on the growth and migration of prostate cancer and the underlying molecular mechanisms.

[1]  Miriam J. Johnson,et al.  Prostate cancer: unmet supportive and palliative care needs: national survey of patients and family carers , 2021, BMJ supportive & palliative care.

[2]  Yuehua Wu,et al.  From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations. , 2021, Biomicrofluidics.

[3]  Kyung-Chul Choi,et al.  Potential Roles of Iridoid Glycosides and Their Underlying Mechanisms against Diverse Cancer Growth and Metastasis: Do They Have an Inhibitory Effect on Cancer Progression? , 2021, Nutrients.

[4]  J. Nam,et al.  Tumor microenvironment and radioresistance , 2021, Experimental & Molecular Medicine.

[5]  Kyung-Chul Choi,et al.  Blockade of transforming growth factor β2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model. , 2021, Cytotherapy.

[6]  K. Tomczak,et al.  Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing , 2021, Proceedings of the National Academy of Sciences.

[7]  I. Endo,et al.  Liver metastases , 2021, Nature Reviews Disease Primers.

[8]  A. Syahir,et al.  Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? , 2021, Frontiers in Oncology.

[9]  M. Krause,et al.  Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response , 2021, Frontiers in Oncology.

[10]  Esak Lee,et al.  In vitro modeling of solid tumor interactions with perfused blood vessels , 2020, Scientific Reports.

[11]  W. Lee,et al.  Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity , 2020, Experimental & Molecular Medicine.

[12]  L. Ding,et al.  The KiSS-1/GPR54 system: Essential roles in physiological homeostasis and cancer biology , 2020, Genes & diseases.

[13]  Hongtao Jin,et al.  CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway , 2020, Frontiers in Oncology.

[14]  D. Ribatti,et al.  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview , 2020, Translational oncology.

[15]  J. Moffat,et al.  A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells , 2019, Oncogene.

[16]  M. Koutsilieris,et al.  The role of kisspeptin system in cancer biology. , 2019, Critical reviews in oncology/hematology.

[17]  Y. Wang,et al.  Long noncoding RNA LUCAT1 promotes migration and invasion of prostate cancer cells by inhibiting KISS1 expression. , 2019, European review for medical and pharmacological sciences.

[18]  G. Thalmann,et al.  Metastases in Prostate Cancer. , 2019, Cold Spring Harbor perspectives in medicine.

[19]  Y. Miyagi,et al.  Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix , 2019, Scientific Reports.

[20]  C. Sorenson,et al.  Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD , 2018, Journal of ophthalmic & vision research.

[21]  S. Radovick,et al.  KISS1/KISS1R in Cancer: Friend or Foe? , 2018, Front. Endocrinol..

[22]  Robert C. G. Martin,et al.  Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma , 2018, BMC Cancer.

[23]  A. LeBeau,et al.  The role of CD133 in cancer: a concise review , 2018, Clinical and Translational Medicine.

[24]  V. Mittal.  Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[25]  Q. Ji,et al.  The role and mechanism of β-arrestins in cancer invasion and metastasis (Review) , 2017, International journal of molecular medicine.

[26]  C. D. Kim,et al.  Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test. , 2017, Journal of pharmacological and toxicological methods.

[27]  Moo-Yeol Lee,et al.  Effects of cigarette smoke extracts on cell cycle, cell migration and endocrine activity in human placental cells. , 2017, Reproductive toxicology.

[28]  Daniel S. Reynolds,et al.  Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment , 2017, Scientific Reports.

[29]  Moo-Yeol Lee,et al.  Cigarette smoke extracts induced the colon cancer migration via regulating epithelial mesenchymal transition and metastatic genes in human colon cancer cells , 2017, Environmental toxicology.

[30]  Kyung-Chul Choi,et al.  Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[31]  Liping Chen,et al.  Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value , 2016, Medicine.

[32]  S. Rajagopal,et al.  The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors* , 2016, The Journal of Biological Chemistry.

[33]  Y. Chun,et al.  Immortalization of human corneal epithelial cells using simian virus 40 large T antigen and cell characterization. , 2016, Journal of pharmacological and toxicological methods.

[34]  Lin Zhao,et al.  Androgen deprivation therapy is associated with diabetes: Evidence from meta‐analysis , 2016, Journal of diabetes investigation.

[35]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[36]  Kyung-Chul Choi,et al.  Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer , 2015, Oncotarget.

[37]  Choung-Soo Kim,et al.  Epidemiology of prostate cancer in South Korea , 2015, Prostate international.

[38]  F. Saad,et al.  Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review. , 2015, BoneKEy reports.

[39]  F. Sotgia,et al.  Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease , 2015, Oncotarget.

[40]  J. Wiest,et al.  Endothelial cell tube formation assay for the in vitro study of angiogenesis. , 2014, Journal of visualized experiments : JoVE.

[41]  H. Vaudry,et al.  Molecular evolution of GPCRs: Kisspeptin/kisspeptin receptors. , 2014, Journal of molecular endocrinology.

[42]  G. Quan,et al.  The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton , 2013, Prostate cancer.

[43]  Y. Toiyama,et al.  Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer. , 2013, Oncology reports.

[44]  Zhong Li,et al.  CD133: a stem cell biomarker and beyond , 2013, Experimental Hematology & Oncology.

[45]  Y. Liu,et al.  Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells , 2013, Proceedings of the National Academy of Sciences.

[46]  Vanessa Marchesi.  Breast cancer: Epithelial–mesenchymal transitions in human breast cancer samples , 2013, Nature Reviews Clinical Oncology.

[47]  W. Grizzle,et al.  Clinical and Biological Significance of KISS1 Expression in Prostate Cancer , 2012, The American journal of pathology.

[48]  Y. Okada,et al.  Prognostic Role of KiSS-1 and Possibility of Therapeutic Modality of Metastin, the Final Peptide of the KiSS-1 Gene, in Urothelial Carcinoma , 2012, Molecular Cancer Therapeutics.

[49]  G. Warnock,et al.  Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. , 2011, World journal of stem cells.

[50]  Mingyao Liu,et al.  Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. , 2011, Cancer research.

[51]  D. Choi,et al.  Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines , 2011, Journal of the Korean Surgical Society.

[52]  N. Yohn,et al.  Phosphatidylinositol 3'-kinase, mTOR, and Glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells , 2011, BMC urology.

[53]  G. M. Di Guglielmo,et al.  GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness , 2011, PloS one.

[54]  A. Ziemienowicz,et al.  Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. , 2011, Annals of botany.

[55]  Yun-Bae Kim,et al.  Potential tumor-tropic effect of genetically engineered stem cells expressing suicide enzymes to selectively target invasive cancer in animal models. , 2011, Anticancer research.

[56]  Jun Yan,et al.  Upregulated CD133 expression in tumorigenesis of colon cancer cells. , 2011, World journal of gastroenterology.

[57]  S. Offermanns,et al.  GPR54 Regulates ERK1/2 Activity and Hypothalamic Gene Expression in a Gαq/11 and β-Arrestin-Dependent Manner , 2010, PloS one.

[58]  William E. Grizzle,et al.  KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model , 2010, Clinical & Experimental Metastasis.

[59]  A. E. Curtis,et al.  Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancer. , 2010, Oncology reports.

[60]  Ying Sun,et al.  Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. , 2010, Anticancer research.

[61]  G. Stein,et al.  Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention , 2008, Expert review of anticancer therapy.

[62]  G. Ahn,et al.  Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.

[63]  Didier Marot,et al.  High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. , 2007, Endocrine-related cancer.

[64]  K. Schmid,et al.  KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study , 2007, Virchows Archiv.

[65]  Hirohisa Yano,et al.  Angiogenesis in Cancer , 2006, Vascular health and risk management.

[66]  Peter Carmeliet,et al.  VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.

[67]  R. Steiner,et al.  Regulation of Kiss1 gene expression in the brain of the female mouse. , 2005, Endocrinology.

[68]  W. Dahut,et al.  Androgen deprivation therapy for prostate cancer. , 2005, JAMA.

[69]  C. Jordan.  Cancer stem cell biology: from leukemia to solid tumors. , 2004, Current opinion in cell biology.

[70]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[71]  M. Ikeguchi,et al.  Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma , 2003, Journal of Cancer Research and Clinical Oncology.

[72]  Manoj Kumar Gupta,et al.  Mechanism and its regulation of tumor-induced angiogenesis. , 2003, World journal of gastroenterology.

[73]  D. Strumberg,et al.  The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer , 2002, Oncology Research and Treatment.

[74]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[75]  R. D'Amato,et al.  Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. , 2001, Journal of the National Cancer Institute.

[76]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[77]  B. O'dowd,et al.  Discovery of a receptor related to the galanin receptors , 1999, FEBS letters.

[78]  J M Trent,et al.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.

[79]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[80]  M. Drescher,et al.  Analysis of Protein Interactions by Surface Plasmon Resonance. , 2018, Advances in protein chemistry and structural biology.

[81]  J. Massagué,et al.  Metastatic Colonization , 2016 .

[82]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[83]  G. Watkins,et al.  KiSS-1 Expression in Human Breast Cancer , 2005, Clinical & Experimental Metastasis.

[84]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.